Uranium Energy Corp. (UEC): UEC revenue beat as inventory sales benefited from uranium prices, while production ramped sharply but missed expectations

Overview

This first take reviews Uranium Energy Corp.'s F4Q26 and FY2026 operating results. Goldman Sachs finds that uranium sales and costs outperformed expectations, while production recovered materially but remained below its forecasts.

Core views

UEC sold 200,000 lbs of U3O8 in F4Q26 at approximately $85.26/lb, producing $17.1mn of revenue. This was materially ahead of Goldman Sachs' expectation for no quarterly uranium sales and above FactSet consensus of $9.0mn. For FY2026, UEC sold 400,000 lbs from inventory at a weighted-average price of $93.13/lb. Goldman Sachs interprets the quarterly sales result as evidence of a solid uranium-price environment. Production improved sharply in F4Q26 but did not meet the institution's forecast. UEC produced 82,744 lbs of precipitated uranium and dried and drummed U3O8 during the quarter, an increase of more than 150% quarter on quarter but below Goldman Sachs' approximately 160,000-lb estimate. The recovery included first production of 17,352 lbs from Burke Hollow and a roughly 200% increase at Christensen Ranch to 65,392 lbs after regulatory delays had weighed on output. Aggregate FY2026 production was 229,294 lbs, below the institution's roughly 307,000-lb forecast. Cost performance was better than expected as quarterly volumes improved. FY2026 total production costs were $39.94/lb, below Goldman Sachs' $43.50/lb estimate. F4Q26 total cost per pound declined to $36.54/lb, compared with the $45.00/lb estimate and $54.61/lb in F3Q26. The report links the sequential cost improvement to higher production volumes during the quarter. Inventory remains a key feature of UEC's position. The company ended FY2026 with 1.26mn lbs of U3O8 inventory, excluding 359,260 lbs of precipitated uranium and dried and drummed material held at processing facilities. Goldman Sachs notes that UEC remains unhedged to uranium prices, so the value realization from this sizeable inventory remains exposed to the uranium-price environment. Goldman Sachs' 12-month price target is $14, based on a 26x EV/EBITDA multiple applied to its F2028 EBITDA estimates, followed by the addition of net cash. The report shows a Buy forecast, a $9.21 price as of the 28 September 2026 close, and 52.0% implied upside.

Analysis framework

Goldman Sachs compares reported quarterly revenue, sales volumes, production and unit costs with its own estimates and FactSet consensus, then explains the operational drivers of production changes at Burke Hollow and Christensen Ranch. Its price target applies a 26x EV/EBITDA multiple to F2028 EBITDA estimates and adds net cash.

Methodology notes

• Valuation methodsEV/EBITDA valuation

  EV/EBITDA multiple valuation

  Goldman Sachs applies a 26x enterprise-value-to-EBITDA multiple to its F2028 EBITDA estimate, then adds net cash to derive the $14 price target.

• Industry AnalysisVolume-price decomposition

  Uranium sales volume and realized-price analysis

  The report evaluates revenue through pounds of U3O8 sold and realized prices per pound, while separately assessing production volumes and unit production costs.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Uranium Energy Corp. (UEC)

  Primary covered company; uranium producer and inventory holder.

  Strengths

  Revenue exceeded expectations through F4Q26 uranium sales, production recovered sharply quarter on quarter, costs beat estimates, and the company retained substantial U3O8 inventory.

  Weaknesses

  F4Q26 and FY2026 production were below Goldman Sachs' forecasts.

  Comparison

  F4Q26 revenue of $17.1mn exceeded FactSet consensus of $9.0mn, while F4Q26 production of 82,744 lbs was below Goldman Sachs' approximately 160,000-lb forecast.

  Risks

  Uranium-price volatility or weakness, uncertain production-ramp timing and pace, higher-than-expected production costs, and dilution from greater liquidity needs.

Key data

• F4Q26 U3O8 sales200,000 lbsSold at approximately $85.26/lb, generating $17.1mn of revenue.
• F4Q26 revenue$17.1mnAbove Goldman Sachs' expectation for no uranium sales and FactSet consensus of $9.0mn.
• F4Q26 production82,744 lbsUp more than 150% quarter on quarter but below Goldman Sachs' approximately 160,000-lb forecast.
• FY2026 production229,294 lbsBelow Goldman Sachs' approximately 307,000-lb forecast.
• F4Q26 production cost$36.54/lbBelow Goldman Sachs' $45.00/lb estimate and down from $54.61/lb in F3Q26.
• FY2026 U3O8 inventory1.26mn lbsExcludes 359,260 lbs of precipitated uranium and dried and drummed U3O8 held at processing facilities.
• 12-month price target$14.00Based on a 26x EV/EBITDA multiple on Goldman Sachs' F2028 EBITDA estimates plus net cash.

Impact & implications

The report indicates that favourable uranium pricing and inventory sales supported revenue, while the operational rebound reduced unit costs. However, production delivery remains below expectations, making the pace and timing of the ramp a central determinant of the investment case.

Risks

• Uranium prices could remain volatile or subdued.
• The timing and pace of the production ramp remain uncertain.
• Production costs could be higher than expected.
• Greater liquidity needs could lead to continued dilution.